市场调查报告书
商品编码
1499437
女性科技市场:按产品、应用、最终用途分类 - 2024-2030 年全球预测Femtech Market by Offering (Products, Services, Software), Application (Fitness & Nutrition, General Health, Gynecology & Sexual Health), End-Use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年女性科技市场规模为359.1亿美元,预计2024年将达408.5亿美元,2030年将达到925.1亿美元,复合年增长率为14.47%。
Femtech 是一类使用专注于女性健康的技术的软体、诊断、产品和服务。这包括各种应用程序,例如生育解决方案、经期追踪应用程式、怀孕和护理、生殖健康和一般健康。 Femtech 的目标是利用科技解决女性独特的健康挑战,并提供适合女性健康和福祉需求的创新解决方案。月经失调、不孕症和更年期等女性健康问题的普及,推动了对女性科技市场提供创新解决方案的需求。然而,网路安全问题严重阻碍了女性科技市场的成长。由于担心资料外洩和未授权存取敏感健康讯息,消费者和医疗保健提供者避免采用女性科技解决方案。女性科技产品和服务的持续技术创新,加上客製化产品的不断增加,为女性科技市场的扩张提供了机会。
主要市场统计 | |
---|---|
基准年[2023] | 359.1亿美元 |
预测年份 [2024] | 408.5亿美元 |
预测年份 [2030] | 925.1亿美元 |
复合年增长率(%) | 14.47% |
区域洞察
在美洲,尤其是北美,市场受益于完善的医疗基础设施和较高的消费者意识,推动了对生育追踪应用、穿戴式健康设备和远端医疗服务等创新的强劲需求。该地区的公司利用丰富的投资环境和活跃的创业投资。数位化应用的不断普及、都市化以及对女性健康问题意识的不断提高推动了亚太地区的发展。中国先进的技术基础设施和庞大的人口正在促进行动医疗应用程式和穿戴式装置在生殖健康方面的发展。日本人口老化和对高品质保健产品的需求正在刺激不孕症治疗和健康追踪方面的投资。同时,印度市场正在蓬勃发展,为女性健康提供价格实惠的行动应用程式和远端医疗服务。在进步的医疗政策和对特定性别医学研究的日益关注的推动下,欧洲、中东和非洲的女性科技市场正在扩大。由于良好的监管和资金筹措机会,欧洲国家尤其为女性科技新兴企业提供了有利的环境。中东市场正在逐渐扩大,人们对不孕症治疗和孕产妇护理的兴趣日益浓厚。非洲的女性科技市场正在兴起,重点是易于获得的生殖健康教育、月经卫生产品和行动医疗服务,以解决医疗保健取得方面的挑战。
FPNV定位矩阵
FPNV 定位矩阵对于评估 Femtech 市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对女性科技市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该细分市场竞争力的宝贵见解,包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对女性科技市场目前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[197 Pages Report] The Femtech Market size was estimated at USD 35.91 billion in 2023 and expected to reach USD 40.85 billion in 2024, at a CAGR 14.47% to reach USD 92.51 billion by 2030.
Femtech is a category of software, diagnostics, products, and services that use technology for focusing on women's health. This includes various applications such as fertility solutions, period-tracking apps, pregnancy and nursing care, reproductive system health, and general wellness. The goal of femtech is to leverage technology to address women's unique health challenges and provide innovative solutions tailored to women's health and wellbeing needs. The high prevalence of women's health issues, such as menstrual disorders, fertility issues, and menopause-related problems, is driving the need for innovative solutions provided by the femtech market. However, cybersecurity concerns significantly hinder the growth of the femtech market as the fear of data breaches and unauthorized access to sensitive health information deters consumers and healthcare providers from adopting femtech solutions. The ongoing innovations in femtech products and services, coupled with the increasing availability of customized products, offers an opportunity for the expansion of the femtech market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 35.91 billion |
Estimated Year [2024] | USD 40.85 billion |
Forecast Year [2030] | USD 92.51 billion |
CAGR (%) | 14.47% |
Regional Insights
In the Americas, particularly in North America, the market benefits from well-established healthcare infrastructure and higher consumer awareness, driving robust demand for innovations, such as fertility tracking apps, wearable health devices, and telehealth services. Companies in this region capitalize on the substantial investment climate and active venture capital presence. The Asia-Pacific region is showcasing market growth fueled by increasing digital adoption, urbanization, and rising awareness of women's health issues. China's advanced tech infrastructure and large population foster mobile health apps and wearables for reproductive health. Japan's aging population and demand for high-quality health products fuel fertility treatments and wellness tracking investments. Meanwhile, India's market thrives with affordable mobile applications and telehealth services for women's health. In the EMEA region, the femtech market is expanding, supported by progressive healthcare policies and a growing focus on gender-specific medical research. European countries, in particular, showcase a favorable environment for femtech startups due to supportive regulations and funding opportunities. The market in the Middle East is gradually growing, with rising interest in fertility treatments and maternal care as awareness grows. Africa's femtech market is emerging, focusing on accessible reproductive health education, menstrual hygiene products, and mobile health services to address healthcare access challenges.
Market Insights
The market dynamics represent an ever-changing landscape of the Femtech Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Femtech Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Femtech Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Strategic Merger Strengthens Keleya's Position in FemTech Market
In a strategic move to enhance support for pregnant women and new mothers, digital platforms keleya and Kinderheldin are merging to operate collectively under the keleya brand. This merger broadens keleya's service portfolio and also consolidates partnerships with 65 health insurance companies, covering about 65% of insured persons in Germany. This merger is poised to significantly impact the FemTech market by extending accessible, expert-led maternal care to a broader audience. [Published On: 2024-05-02]
Launch of Femtech Canada Marks a Milestone in Women's Health Innovation
Femtech Canada, a pioneering women's health network initiative by Innovation Factory, officially launched in Toronto, Ontario, devoted to women's health innovation, commercialization, and investment. The initiative aims to serve the health and wellness needs of women, girls, non-binary individuals, trans people, and those assigned female at birth, promoting a more inclusive healthcare environment. [Published On: 2024-02-01]
Strategic Merger to Propel Growth in Swedish Femtech Market
Peptonic, known for its medical treatments and lifestyle products, and Pharmiva, currently launching Vernivia for bacterial vaginosis treatment, have announced plans to merge to enhance both companies' market positioning and product offerings. The merger, expected to foster growth and expansion into new markets, must be approved by both companies' boards and an extraordinary general meeting in Pharmiva. [Published On: 2023-06-19]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Femtech Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Femtech Market, highlighting leading vendors and their innovative profiles. These include Allara Health, Apple Inc., Athena Feminine Technologies, Athena Feminine Technologies, Inc., AVA Sciences by FemTech Health, Bloomlife, Canopie Inc., Carrot Fertility, Inc., Chiaro Technology Limited, Chorus Health Inc., Cleo Labs, Inc., Clue by Biowink GmbH, Elektra Health, Elvie, Everlywell, Inc., Fitbit LLC by Google, Inc., Flo Health UK Limited, Flo Health, Inc., FOLX Health, Inc., Future Family, Inc., Garmin Ltd., Glow Inc., HeraMED, INTIMINA, iSono Health, Kindbody, Koninklijke Philips N.V., Maven Clinic Co., Natural Cycles USA Corp, NextGen Jane, NUROKOR Ltd., Nuvo Cares, Nuvo Group Ltd., Organon & Co., Renovia Inc., Rosy Wellness, Inc., Rume Medical Group, Inc., Samsung Electronics Co., Ltd., Sera Prognostics, Thirty Madison company, Tia, Inc., Unified Women's Healthcare, Univfy Inc., Willow Innovations, Inc., and Wolomi.
Market Segmentation & Coverage